nodes	percent_of_prediction	percent_of_DWPC	metapath
Dolutegravir—Hepatitis C—Bupropion—obesity	0.0295	0.0506	CcSEcCtD
Dolutegravir—UGT1A1—Irinotecan Pathway—NPC1—obesity	0.027	0.0664	CbGpPWpGaD
Dolutegravir—POU2F2—Ectoderm Differentiation—MKS1—obesity	0.0227	0.0558	CbGpPWpGaD
Dolutegravir—UGT1A1—Irinotecan Pathway—CES1—obesity	0.0187	0.046	CbGpPWpGaD
Dolutegravir—Autoimmune disorder—Orlistat—obesity	0.0182	0.0311	CcSEcCtD
Dolutegravir—POU2F2—Validated transcriptional targets of deltaNp63 isoforms—IGFBP3—obesity	0.0177	0.0436	CbGpPWpGaD
Dolutegravir—POU2F2—Validated transcriptional targets of deltaNp63 isoforms—FASN—obesity	0.0152	0.0372	CbGpPWpGaD
Dolutegravir—POU2F2—Ectoderm Differentiation—HMGB2—obesity	0.0146	0.036	CbGpPWpGaD
Dolutegravir—Musculoskeletal disorder—Bupropion—obesity	0.0143	0.0246	CcSEcCtD
Dolutegravir—Rash macular—Sibutramine—obesity	0.0143	0.0245	CcSEcCtD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—ACADM—obesity	0.0125	0.0307	CbGpPWpGaD
Dolutegravir—POU2F2—Ectoderm Differentiation—PPARD—obesity	0.0122	0.0299	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—SLC9A3—obesity	0.0118	0.0291	CbGpPWpGaD
Dolutegravir—Prurigo—Bupropion—obesity	0.0111	0.019	CcSEcCtD
Dolutegravir—Abdominal pain upper—Phendimetrazine—obesity	0.0108	0.0184	CcSEcCtD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—PPARGC1B—obesity	0.00974	0.0239	CbGpPWpGaD
Dolutegravir—UGT1A1—Estrogen metabolism—STS—obesity	0.00918	0.0226	CbGpPWpGaD
Dolutegravir—UGT1A1—Heme degradation—HMOX1—obesity	0.00888	0.0218	CbGpPWpGaD
Dolutegravir—POU2F2—Ectoderm Differentiation—TNFRSF11B—obesity	0.00841	0.0207	CbGpPWpGaD
Dolutegravir—Renal impairment—Cimetidine—obesity	0.00839	0.0144	CcSEcCtD
Dolutegravir—Rash macular—Topiramate—obesity	0.00796	0.0136	CcSEcCtD
Dolutegravir—Blood creatinine increased—Cimetidine—obesity	0.00748	0.0128	CcSEcCtD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—PRKAR2B—obesity	0.00722	0.0177	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—CPT1A—obesity	0.00697	0.0171	CbGpPWpGaD
Dolutegravir—Abdominal discomfort—Diethylpropion—obesity	0.00695	0.0119	CcSEcCtD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—GCK—obesity	0.0068	0.0167	CbGpPWpGaD
Dolutegravir—POU2F2—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—obesity	0.00665	0.0163	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—TF—obesity	0.00648	0.0159	CbGpPWpGaD
Dolutegravir—Neutropenia—Cimetidine—obesity	0.00645	0.011	CcSEcCtD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—SLC6A4—obesity	0.0061	0.015	CbGpPWpGaD
Dolutegravir—Inflammation—Sibutramine—obesity	0.00606	0.0104	CcSEcCtD
Dolutegravir—Renal failure—Cimetidine—obesity	0.00605	0.0104	CcSEcCtD
Dolutegravir—Insomnia—Methamphetamine—obesity	0.00597	0.0102	CcSEcCtD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—NTRK2—obesity	0.00593	0.0146	CbGpPWpGaD
Dolutegravir—Abnormal dreams—Sibutramine—obesity	0.00581	0.00994	CcSEcCtD
Dolutegravir—Insomnia—Benzphetamine—obesity	0.00576	0.00985	CcSEcCtD
Dolutegravir—UGT1A1—Irinotecan Pathway—BCHE—obesity	0.00574	0.0141	CbGpPWpGaD
Dolutegravir—Gastrointestinal disorder—Methamphetamine—obesity	0.0057	0.00975	CcSEcCtD
Dolutegravir—Hepatitis—Cimetidine—obesity	0.00553	0.00945	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Benzphetamine—obesity	0.00549	0.0094	CcSEcCtD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—ESR2—obesity	0.00547	0.0134	CbGpPWpGaD
Dolutegravir—UGT1A1—Glucuronidation—HK1—obesity	0.00537	0.0132	CbGpPWpGaD
Dolutegravir—Insomnia—Phendimetrazine—obesity	0.00525	0.00898	CcSEcCtD
Dolutegravir—UGT1A1—Constitutive Androstane Receptor Pathway—NR1I3—obesity	0.00516	0.0127	CbGpPWpGaD
Dolutegravir—POU2F2—BCR signaling pathway—PIK3R1—obesity	0.00512	0.0126	CbGpPWpGaD
Dolutegravir—Abnormal dreams—Bupropion—obesity	0.00506	0.00867	CcSEcCtD
Dolutegravir—Hypersensitivity—Methamphetamine—obesity	0.00486	0.00832	CcSEcCtD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—AR—obesity	0.00483	0.0119	CbGpPWpGaD
Dolutegravir—Flatulence—Cimetidine—obesity	0.00474	0.00811	CcSEcCtD
Dolutegravir—Hypersensitivity—Benzphetamine—obesity	0.00469	0.00802	CcSEcCtD
Dolutegravir—Rash maculo-papular—Bupropion—obesity	0.00466	0.00797	CcSEcCtD
Dolutegravir—Abdominal pain—Phendimetrazine—obesity	0.00459	0.00785	CcSEcCtD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—PPARGC1A—obesity	0.00456	0.0112	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—GNB3—obesity	0.00456	0.0112	CbGpPWpGaD
Dolutegravir—Diarrhoea—Methamphetamine—obesity	0.00452	0.00773	CcSEcCtD
Dolutegravir—Renal impairment—Sibutramine—obesity	0.00448	0.00767	CcSEcCtD
Dolutegravir—UGT1A1—Estrogen metabolism—NQO1—obesity	0.00448	0.011	CbGpPWpGaD
Dolutegravir—Insomnia—Phenylpropanolamine—obesity	0.00448	0.00767	CcSEcCtD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—BDNF—obesity	0.00443	0.0109	CbGpPWpGaD
Dolutegravir—Dizziness—Methamphetamine—obesity	0.00436	0.00747	CcSEcCtD
Dolutegravir—Diarrhoea—Benzphetamine—obesity	0.00435	0.00745	CcSEcCtD
Dolutegravir—Insomnia—Phentermine—obesity	0.00429	0.00734	CcSEcCtD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—IL10—obesity	0.00423	0.0104	CbGpPWpGaD
Dolutegravir—Dizziness—Benzphetamine—obesity	0.00421	0.0072	CcSEcCtD
Dolutegravir—Headache—Methamphetamine—obesity	0.00414	0.00708	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Phentermine—obesity	0.00409	0.007	CcSEcCtD
Dolutegravir—Fatigue—Phentermine—obesity	0.00409	0.007	CcSEcCtD
Dolutegravir—Abdominal pain upper—Orlistat—obesity	0.00403	0.00689	CcSEcCtD
Dolutegravir—Blood creatinine increased—Sibutramine—obesity	0.004	0.00684	CcSEcCtD
Dolutegravir—POU2F2—BCR signaling pathway—MAPK8—obesity	0.004	0.00982	CbGpPWpGaD
Dolutegravir—Headache—Benzphetamine—obesity	0.00399	0.00682	CcSEcCtD
Dolutegravir—Diarrhoea—Phendimetrazine—obesity	0.00397	0.00679	CcSEcCtD
Dolutegravir—UGT1A1—Constitutive Androstane Receptor Pathway—SULT2A1—obesity	0.00391	0.00961	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—NR3C1—obesity	0.00391	0.00961	CbGpPWpGaD
Dolutegravir—UGT1A1—Porphyrin metabolism—HMOX1—obesity	0.00386	0.00948	CbGpPWpGaD
Dolutegravir—Dizziness—Phendimetrazine—obesity	0.00384	0.00656	CcSEcCtD
Dolutegravir—Nausea—Benzphetamine—obesity	0.00378	0.00647	CcSEcCtD
Dolutegravir—Alanine aminotransferase increased—Sibutramine—obesity	0.00376	0.00644	CcSEcCtD
Dolutegravir—UGT1A1—Estrogen metabolism—COMT—obesity	0.00376	0.00923	CbGpPWpGaD
Dolutegravir—Abdominal pain—Phentermine—obesity	0.00375	0.00641	CcSEcCtD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—HTR2A—obesity	0.00374	0.00919	CbGpPWpGaD
Dolutegravir—Insomnia—Diethylpropion—obesity	0.00373	0.00638	CcSEcCtD
Dolutegravir—Abdominal discomfort—Orlistat—obesity	0.00365	0.00625	CcSEcCtD
Dolutegravir—Hypersensitivity—Phenylpropanolamine—obesity	0.00365	0.00625	CcSEcCtD
Dolutegravir—Headache—Phendimetrazine—obesity	0.00363	0.00622	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Diethylpropion—obesity	0.00356	0.00609	CcSEcCtD
Dolutegravir—Nausea—Phendimetrazine—obesity	0.00345	0.0059	CcSEcCtD
Dolutegravir—Asthenia—Phentermine—obesity	0.0034	0.00582	CcSEcCtD
Dolutegravir—Abdominal pain upper—Bupropion—obesity	0.0034	0.00581	CcSEcCtD
Dolutegravir—Fatigue—Cimetidine—obesity	0.00338	0.00579	CcSEcCtD
Dolutegravir—Renal failure—Orlistat—obesity	0.00334	0.00571	CcSEcCtD
Dolutegravir—Hyperglycaemia—Sibutramine—obesity	0.00333	0.00569	CcSEcCtD
Dolutegravir—Dizziness—Phenylpropanolamine—obesity	0.00328	0.00561	CcSEcCtD
Dolutegravir—POU2F2—adipose tissue—obesity	0.00327	0.381	CbGeAlD
Dolutegravir—Diarrhoea—Phentermine—obesity	0.00324	0.00555	CcSEcCtD
Dolutegravir—Renal failure—Sibutramine—obesity	0.00323	0.00553	CcSEcCtD
Dolutegravir—POU2F2—Ectoderm Differentiation—CCL2—obesity	0.00322	0.00792	CbGpPWpGaD
Dolutegravir—Hepatobiliary disease—Orlistat—obesity	0.00321	0.0055	CcSEcCtD
Dolutegravir—Vomiting—Phenylpropanolamine—obesity	0.00315	0.00539	CcSEcCtD
Dolutegravir—Dizziness—Phentermine—obesity	0.00314	0.00537	CcSEcCtD
Dolutegravir—Rash—Phenylpropanolamine—obesity	0.00312	0.00535	CcSEcCtD
Dolutegravir—Dermatitis—Phenylpropanolamine—obesity	0.00312	0.00534	CcSEcCtD
Dolutegravir—Abdominal discomfort—Bupropion—obesity	0.00308	0.00527	CcSEcCtD
Dolutegravir—Hepatitis—Orlistat—obesity	0.00305	0.00522	CcSEcCtD
Dolutegravir—Vomiting—Phentermine—obesity	0.00302	0.00516	CcSEcCtD
Dolutegravir—Urinary tract disorder—Orlistat—obesity	0.00301	0.00515	CcSEcCtD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IGFBP1—obesity	0.003	0.00738	CbGpPWpGaD
Dolutegravir—Urethral disorder—Orlistat—obesity	0.00299	0.00512	CcSEcCtD
Dolutegravir—Rash—Phentermine—obesity	0.00299	0.00512	CcSEcCtD
Dolutegravir—Dermatitis—Phentermine—obesity	0.00299	0.00511	CcSEcCtD
Dolutegravir—Headache—Phentermine—obesity	0.00297	0.00508	CcSEcCtD
Dolutegravir—Rash maculo-papular—Topiramate—obesity	0.00297	0.00508	CcSEcCtD
Dolutegravir—Nausea—Phenylpropanolamine—obesity	0.00294	0.00504	CcSEcCtD
Dolutegravir—POU2F2—adrenal gland—obesity	0.00293	0.341	CbGeAlD
Dolutegravir—Hyperglycaemia—Bupropion—obesity	0.0029	0.00496	CcSEcCtD
Dolutegravir—Hypersensitivity—Cimetidine—obesity	0.00289	0.00495	CcSEcCtD
Dolutegravir—POU2F2—BCR signaling pathway—PIK3CA—obesity	0.00288	0.00708	CbGpPWpGaD
Dolutegravir—UGT1A1—NRF2 pathway—CES1—obesity	0.00287	0.00705	CbGpPWpGaD
Dolutegravir—Diarrhoea—Diethylpropion—obesity	0.00282	0.00483	CcSEcCtD
Dolutegravir—Nausea—Phentermine—obesity	0.00282	0.00482	CcSEcCtD
Dolutegravir—Asthenia—Cimetidine—obesity	0.00282	0.00482	CcSEcCtD
Dolutegravir—Immune system disorder—Orlistat—obesity	0.00276	0.00471	CcSEcCtD
Dolutegravir—Dizziness—Diethylpropion—obesity	0.00273	0.00467	CcSEcCtD
Dolutegravir—Diarrhoea—Cimetidine—obesity	0.00269	0.0046	CcSEcCtD
Dolutegravir—Mental disorder—Orlistat—obesity	0.00267	0.00457	CcSEcCtD
Dolutegravir—UGT1A1—NRF2 pathway—ME1—obesity	0.00267	0.00656	CbGpPWpGaD
Dolutegravir—Immune system disorder—Sibutramine—obesity	0.00267	0.00456	CcSEcCtD
Dolutegravir—Vomiting—Diethylpropion—obesity	0.00262	0.00449	CcSEcCtD
Dolutegravir—Flatulence—Orlistat—obesity	0.00262	0.00448	CcSEcCtD
Dolutegravir—Rash—Diethylpropion—obesity	0.0026	0.00445	CcSEcCtD
Dolutegravir—Dermatitis—Diethylpropion—obesity	0.0026	0.00445	CcSEcCtD
Dolutegravir—Dizziness—Cimetidine—obesity	0.0026	0.00444	CcSEcCtD
Dolutegravir—UGT1A1—Constitutive Androstane Receptor Pathway—NCOA1—obesity	0.00259	0.00636	CbGpPWpGaD
Dolutegravir—Headache—Diethylpropion—obesity	0.00258	0.00442	CcSEcCtD
Dolutegravir—Hepatitis—Bupropion—obesity	0.00257	0.0044	CcSEcCtD
Dolutegravir—Urinary tract disorder—Bupropion—obesity	0.00254	0.00435	CcSEcCtD
Dolutegravir—Flatulence—Sibutramine—obesity	0.00253	0.00433	CcSEcCtD
Dolutegravir—Urethral disorder—Bupropion—obesity	0.00252	0.00432	CcSEcCtD
Dolutegravir—Vomiting—Cimetidine—obesity	0.0025	0.00427	CcSEcCtD
Dolutegravir—Rash—Cimetidine—obesity	0.00248	0.00423	CcSEcCtD
Dolutegravir—Dermatitis—Cimetidine—obesity	0.00247	0.00423	CcSEcCtD
Dolutegravir—Headache—Cimetidine—obesity	0.00246	0.00421	CcSEcCtD
Dolutegravir—Nausea—Diethylpropion—obesity	0.00245	0.00419	CcSEcCtD
Dolutegravir—Vertigo—Orlistat—obesity	0.00239	0.00408	CcSEcCtD
Dolutegravir—POU2F2—BCR signaling pathway—AKT1—obesity	0.00235	0.00578	CbGpPWpGaD
Dolutegravir—UGT1A1—Constitutive Androstane Receptor Pathway—PPARGC1A—obesity	0.00234	0.00574	CbGpPWpGaD
Dolutegravir—Nausea—Cimetidine—obesity	0.00233	0.00399	CcSEcCtD
Dolutegravir—Immune system disorder—Bupropion—obesity	0.00232	0.00398	CcSEcCtD
Dolutegravir—Vertigo—Sibutramine—obesity	0.00231	0.00395	CcSEcCtD
Dolutegravir—UGT1A1—NRF2 pathway—FTL—obesity	0.00227	0.00558	CbGpPWpGaD
Dolutegravir—Mental disorder—Bupropion—obesity	0.00225	0.00386	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.00225	0.00384	CcSEcCtD
Dolutegravir—Blood creatinine increased—Topiramate—obesity	0.00222	0.0038	CcSEcCtD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—IL1B—obesity	0.00222	0.00545	CbGpPWpGaD
Dolutegravir—Flatulence—Bupropion—obesity	0.00221	0.00378	CcSEcCtD
Dolutegravir—UGT1A1—NRF2 pathway—SLC6A14—obesity	0.00218	0.00535	CbGpPWpGaD
Dolutegravir—Abdominal pain upper—Topiramate—obesity	0.00216	0.0037	CcSEcCtD
Dolutegravir—Nervous system disorder—Orlistat—obesity	0.00213	0.00364	CcSEcCtD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—NQO1—obesity	0.00212	0.0052	CbGpPWpGaD
Dolutegravir—UGT1A1—Constitutive Androstane Receptor Pathway—FOXO1—obesity	0.00211	0.00519	CbGpPWpGaD
Dolutegravir—Skin disorder—Orlistat—obesity	0.0021	0.0036	CcSEcCtD
Dolutegravir—Alanine aminotransferase increased—Topiramate—obesity	0.00209	0.00358	CcSEcCtD
Dolutegravir—Skin disorder—Sibutramine—obesity	0.00204	0.00349	CcSEcCtD
Dolutegravir—Vertigo—Bupropion—obesity	0.00201	0.00344	CcSEcCtD
Dolutegravir—Abdominal discomfort—Topiramate—obesity	0.00196	0.00336	CcSEcCtD
Dolutegravir—Insomnia—Orlistat—obesity	0.00196	0.00335	CcSEcCtD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—NCOA1—obesity	0.00194	0.00476	CbGpPWpGaD
Dolutegravir—Neutropenia—Topiramate—obesity	0.00192	0.00328	CcSEcCtD
Dolutegravir—POU2F2—Ectoderm Differentiation—MYC—obesity	0.0019	0.00468	CbGpPWpGaD
Dolutegravir—Insomnia—Sibutramine—obesity	0.0019	0.00325	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.00189	0.00324	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Orlistat—obesity	0.00187	0.0032	CcSEcCtD
Dolutegravir—Fatigue—Orlistat—obesity	0.00187	0.0032	CcSEcCtD
Dolutegravir—Hyperglycaemia—Topiramate—obesity	0.00185	0.00316	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Sibutramine—obesity	0.00181	0.0031	CcSEcCtD
Dolutegravir—Renal failure—Topiramate—obesity	0.0018	0.00307	CcSEcCtD
Dolutegravir—Nervous system disorder—Bupropion—obesity	0.00179	0.00307	CcSEcCtD
Dolutegravir—Skin disorder—Bupropion—obesity	0.00178	0.00304	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Orlistat—obesity	0.00177	0.00303	CcSEcCtD
Dolutegravir—UGT1A1—Phase II conjugation—SULT2A1—obesity	0.00174	0.00428	CbGpPWpGaD
Dolutegravir—Gastrointestinal pain—Sibutramine—obesity	0.00172	0.00293	CcSEcCtD
Dolutegravir—Abdominal pain—Orlistat—obesity	0.00171	0.00293	CcSEcCtD
Dolutegravir—UGT1A1—NRF2 pathway—PPARD—obesity	0.00168	0.00414	CbGpPWpGaD
Dolutegravir—Abdominal pain—Sibutramine—obesity	0.00166	0.00284	CcSEcCtD
Dolutegravir—Insomnia—Bupropion—obesity	0.00165	0.00283	CcSEcCtD
Dolutegravir—Hepatitis—Topiramate—obesity	0.00164	0.00281	CcSEcCtD
Dolutegravir—Urinary tract disorder—Topiramate—obesity	0.00162	0.00277	CcSEcCtD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—TNF—obesity	0.00161	0.00395	CbGpPWpGaD
Dolutegravir—Urethral disorder—Topiramate—obesity	0.00161	0.00275	CcSEcCtD
Dolutegravir—Hypersensitivity—Orlistat—obesity	0.0016	0.00273	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Bupropion—obesity	0.00158	0.0027	CcSEcCtD
Dolutegravir—Fatigue—Bupropion—obesity	0.00158	0.0027	CcSEcCtD
Dolutegravir—Asthenia—Orlistat—obesity	0.00155	0.00266	CcSEcCtD
Dolutegravir—Hypersensitivity—Sibutramine—obesity	0.00155	0.00264	CcSEcCtD
Dolutegravir—Pruritus—Orlistat—obesity	0.00153	0.00262	CcSEcCtD
Dolutegravir—UGT1A1—Biological oxidations—CYP26B1—obesity	0.00151	0.00371	CbGpPWpGaD
Dolutegravir—Asthenia—Sibutramine—obesity	0.0015	0.00257	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Bupropion—obesity	0.0015	0.00256	CcSEcCtD
Dolutegravir—UGT1A1—Metapathway biotransformation—CYP26B1—obesity	0.00149	0.00366	CbGpPWpGaD
Dolutegravir—Pruritus—Sibutramine—obesity	0.00148	0.00254	CcSEcCtD
Dolutegravir—Diarrhoea—Orlistat—obesity	0.00148	0.00254	CcSEcCtD
Dolutegravir—Immune system disorder—Topiramate—obesity	0.00148	0.00253	CcSEcCtD
Dolutegravir—Abdominal pain—Bupropion—obesity	0.00145	0.00247	CcSEcCtD
Dolutegravir—Mental disorder—Topiramate—obesity	0.00144	0.00246	CcSEcCtD
Dolutegravir—Diarrhoea—Sibutramine—obesity	0.00144	0.00246	CcSEcCtD
Dolutegravir—Dizziness—Orlistat—obesity	0.00143	0.00245	CcSEcCtD
Dolutegravir—Flatulence—Topiramate—obesity	0.00141	0.00241	CcSEcCtD
Dolutegravir—Dizziness—Sibutramine—obesity	0.00139	0.00237	CcSEcCtD
Dolutegravir—Vomiting—Orlistat—obesity	0.00138	0.00236	CcSEcCtD
Dolutegravir—Rash—Orlistat—obesity	0.00137	0.00234	CcSEcCtD
Dolutegravir—UGT1A1—NRF2 pathway—G6PD—obesity	0.00137	0.00336	CbGpPWpGaD
Dolutegravir—Dermatitis—Orlistat—obesity	0.00137	0.00234	CcSEcCtD
Dolutegravir—Headache—Orlistat—obesity	0.00136	0.00232	CcSEcCtD
Dolutegravir—Hypersensitivity—Bupropion—obesity	0.00135	0.0023	CcSEcCtD
Dolutegravir—Vomiting—Sibutramine—obesity	0.00133	0.00228	CcSEcCtD
Dolutegravir—UGT1A1—Biological oxidations—ADH1B—obesity	0.00132	0.00325	CbGpPWpGaD
Dolutegravir—Rash—Sibutramine—obesity	0.00132	0.00226	CcSEcCtD
Dolutegravir—Dermatitis—Sibutramine—obesity	0.00132	0.00226	CcSEcCtD
Dolutegravir—Headache—Sibutramine—obesity	0.00131	0.00225	CcSEcCtD
Dolutegravir—Asthenia—Bupropion—obesity	0.00131	0.00224	CcSEcCtD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—IL6—obesity	0.0013	0.00319	CbGpPWpGaD
Dolutegravir—Pruritus—Bupropion—obesity	0.00129	0.00221	CcSEcCtD
Dolutegravir—Nausea—Orlistat—obesity	0.00129	0.0022	CcSEcCtD
Dolutegravir—Vertigo—Topiramate—obesity	0.00128	0.00219	CcSEcCtD
Dolutegravir—Diarrhoea—Bupropion—obesity	0.00125	0.00214	CcSEcCtD
Dolutegravir—Nausea—Sibutramine—obesity	0.00125	0.00213	CcSEcCtD
Dolutegravir—Dizziness—Bupropion—obesity	0.00121	0.00207	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.00121	0.00206	CcSEcCtD
Dolutegravir—UGT1A1—Phase II conjugation—GGT1—obesity	0.00117	0.00287	CbGpPWpGaD
Dolutegravir—Vomiting—Bupropion—obesity	0.00116	0.00199	CcSEcCtD
Dolutegravir—Rash—Bupropion—obesity	0.00115	0.00197	CcSEcCtD
Dolutegravir—Dermatitis—Bupropion—obesity	0.00115	0.00197	CcSEcCtD
Dolutegravir—Headache—Bupropion—obesity	0.00115	0.00196	CcSEcCtD
Dolutegravir—Nervous system disorder—Topiramate—obesity	0.00114	0.00195	CcSEcCtD
Dolutegravir—Skin disorder—Topiramate—obesity	0.00113	0.00194	CcSEcCtD
Dolutegravir—UGT1A1—NRF2 pathway—GPX3—obesity	0.00111	0.00272	CbGpPWpGaD
Dolutegravir—Nausea—Bupropion—obesity	0.00109	0.00186	CcSEcCtD
Dolutegravir—UGT1A1—Phase II conjugation—COMT—obesity	0.00106	0.00259	CbGpPWpGaD
Dolutegravir—Insomnia—Topiramate—obesity	0.00105	0.0018	CcSEcCtD
Dolutegravir—UGT1A1—Biological oxidations—SULT2A1—obesity	0.00102	0.0025	CbGpPWpGaD
Dolutegravir—Gastrointestinal disorder—Topiramate—obesity	0.00101	0.00172	CcSEcCtD
Dolutegravir—UGT1A1—Metapathway biotransformation—SULT2A1—obesity	0.001	0.00247	CbGpPWpGaD
Dolutegravir—Fatigue—Topiramate—obesity	0.001	0.00172	CcSEcCtD
Dolutegravir—UGT1A1—Metapathway biotransformation—GPX3—obesity	0.000959	0.00236	CbGpPWpGaD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—obesity	0.000954	0.00234	CbGpPWpGaD
Dolutegravir—Gastrointestinal pain—Topiramate—obesity	0.000953	0.00163	CcSEcCtD
Dolutegravir—UGT1A1—NRF2 pathway—SLC6A4—obesity	0.000929	0.00228	CbGpPWpGaD
Dolutegravir—UGT1A1—digestive system—obesity	0.000928	0.108	CbGeAlD
Dolutegravir—Abdominal pain—Topiramate—obesity	0.000921	0.00158	CcSEcCtD
Dolutegravir—Hypersensitivity—Topiramate—obesity	0.000858	0.00147	CcSEcCtD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—obesity	0.000851	0.00209	CbGpPWpGaD
Dolutegravir—UGT1A1—Metapathway biotransformation—AKR1C3—obesity	0.000841	0.00207	CbGpPWpGaD
Dolutegravir—UGT1A1—NRF2 pathway—NQO1—obesity	0.00084	0.00206	CbGpPWpGaD
Dolutegravir—Asthenia—Topiramate—obesity	0.000836	0.00143	CcSEcCtD
Dolutegravir—Pruritus—Topiramate—obesity	0.000824	0.00141	CcSEcCtD
Dolutegravir—UGT1A1—NRF2 pathway—SLC2A4—obesity	0.000805	0.00198	CbGpPWpGaD
Dolutegravir—Diarrhoea—Topiramate—obesity	0.000797	0.00136	CcSEcCtD
Dolutegravir—UGT1A1—NRF2 pathway—GGT1—obesity	0.00078	0.00192	CbGpPWpGaD
Dolutegravir—Dizziness—Topiramate—obesity	0.00077	0.00132	CcSEcCtD
Dolutegravir—UGT1A1—endocrine gland—obesity	0.000767	0.0893	CbGeAlD
Dolutegravir—UGT1A1—Biological oxidations—CYP2E1—obesity	0.000745	0.00183	CbGpPWpGaD
Dolutegravir—Vomiting—Topiramate—obesity	0.000741	0.00127	CcSEcCtD
Dolutegravir—UGT1A1—Metapathway biotransformation—CYP2E1—obesity	0.000735	0.00181	CbGpPWpGaD
Dolutegravir—Rash—Topiramate—obesity	0.000734	0.00126	CcSEcCtD
Dolutegravir—Dermatitis—Topiramate—obesity	0.000734	0.00126	CcSEcCtD
Dolutegravir—Headache—Topiramate—obesity	0.00073	0.00125	CcSEcCtD
Dolutegravir—Nausea—Topiramate—obesity	0.000692	0.00118	CcSEcCtD
Dolutegravir—UGT1A1—liver—obesity	0.000692	0.0806	CbGeAlD
Dolutegravir—UGT1A1—NRF2 pathway—HMOX1—obesity	0.000691	0.0017	CbGpPWpGaD
Dolutegravir—UGT1A1—Biological oxidations—GGT1—obesity	0.000684	0.00168	CbGpPWpGaD
Dolutegravir—UGT1A1—Biological oxidations—NCOA1—obesity	0.000674	0.00166	CbGpPWpGaD
Dolutegravir—UGT1A1—Biological oxidations—CYP19A1—obesity	0.000664	0.00163	CbGpPWpGaD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—obesity	0.000661	0.00162	CbGpPWpGaD
Dolutegravir—UGT1A1—Metapathway biotransformation—CYP19A1—obesity	0.000655	0.00161	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CA3—obesity	0.000621	0.00153	CbGpPWpGaD
Dolutegravir—UGT1A1—Biological oxidations—COMT—obesity	0.000617	0.00152	CbGpPWpGaD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—obesity	0.000617	0.00152	CbGpPWpGaD
Dolutegravir—UGT1A1—Metapathway biotransformation—COMT—obesity	0.000609	0.0015	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—GLRX—obesity	0.000528	0.0013	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ETFDH—obesity	0.000471	0.00116	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—OTC—obesity	0.000471	0.00116	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—INSIG2—obesity	0.000471	0.00116	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PPM1L—obesity	0.000471	0.00116	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—INPP5E—obesity	0.000431	0.00106	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—UQCRC2—obesity	0.000431	0.00106	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—GPT—obesity	0.000431	0.00106	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ME1—obesity	0.0004	0.000984	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ALDH6A1—obesity	0.0004	0.000984	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—SUCLG2—obesity	0.0004	0.000984	CbGpPWpGaD
Dolutegravir—UGT1A1—Biological oxidations—POMC—obesity	0.000399	0.000981	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—COX7C—obesity	0.000376	0.000925	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PNPLA3—obesity	0.000376	0.000925	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—UCP1—obesity	0.000376	0.000925	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—DGAT2—obesity	0.000357	0.000877	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CS—obesity	0.000357	0.000877	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CPS1—obesity	0.000357	0.000877	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—SUCLA2—obesity	0.000357	0.000877	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—MUT—obesity	0.00034	0.000836	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—LIPE—obesity	0.00034	0.000836	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CYB5A—obesity	0.000326	0.000802	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—DGAT1—obesity	0.000326	0.000802	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ACLY—obesity	0.000314	0.000772	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ALOX12—obesity	0.000303	0.000746	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ENPP1—obesity	0.000303	0.000746	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—HMGCS1—obesity	0.000294	0.000722	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PFKFB3—obesity	0.000285	0.000701	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ACADM—obesity	0.000285	0.000701	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ANGPTL4—obesity	0.000285	0.000701	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PNPLA2—obesity	0.000285	0.000701	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—SAT1—obesity	0.000285	0.000701	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PLIN1—obesity	0.000285	0.000701	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—OXCT1—obesity	0.000277	0.000682	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ACACB—obesity	0.000277	0.000682	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CYTB—obesity	0.000277	0.000682	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PNLIP—obesity	0.00027	0.000664	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—SRD5A1—obesity	0.00027	0.000664	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—SDC3—obesity	0.000264	0.000649	CbGpPWpGaD
Dolutegravir—UGT1A1—NRF2 pathway—TGFB1—obesity	0.000262	0.000645	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—STS—obesity	0.000258	0.000634	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—HK2—obesity	0.000258	0.000634	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CYP26B1—obesity	0.000258	0.000634	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PPARD—obesity	0.000252	0.00062	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—SLC27A1—obesity	0.000247	0.000608	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—FABP4—obesity	0.000243	0.000596	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—GLUL—obesity	0.000243	0.000596	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—UCP3—obesity	0.00023	0.000565	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—UCP2—obesity	0.00023	0.000565	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ECHS1—obesity	0.00023	0.000565	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—HSD11B1—obesity	0.00023	0.000565	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ADH1B—obesity	0.000226	0.000556	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PPARGC1B—obesity	0.000223	0.000547	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ACSL1—obesity	0.000223	0.000547	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—GPAM—obesity	0.000223	0.000547	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PCK1—obesity	0.000216	0.000531	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—HADH—obesity	0.000216	0.000531	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—FADS1—obesity	0.000216	0.000531	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ACP5—obesity	0.00021	0.000517	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—G6PD—obesity	0.000205	0.000504	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—SREBF2—obesity	0.000202	0.000497	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—HK1—obesity	0.000202	0.000497	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—LPA—obesity	0.000196	0.00048	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—LPIN1—obesity	0.000191	0.00047	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—APOA5—obesity	0.000187	0.000461	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CLOCK—obesity	0.000179	0.000439	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—SLC22A1—obesity	0.000179	0.000439	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—SULT2A1—obesity	0.000174	0.000428	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—GLP1R—obesity	0.000174	0.000428	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—DPYD—obesity	0.000171	0.000421	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PRKAR2B—obesity	0.000165	0.000405	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—DCN—obesity	0.000164	0.000403	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CPT1A—obesity	0.000159	0.000392	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—NAMPT—obesity	0.000156	0.000384	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—LIPC—obesity	0.000155	0.000382	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—GCK—obesity	0.000155	0.000382	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—APOC3—obesity	0.000154	0.000379	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CETP—obesity	0.00015	0.000368	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—SDC1—obesity	0.000148	0.000364	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—AKR1C3—obesity	0.000146	0.000358	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—SCARB1—obesity	0.000143	0.000353	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—SREBF1—obesity	0.000139	0.000342	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—GOT2—obesity	0.000136	0.000333	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—FASN—obesity	0.000133	0.000326	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—BCHE—obesity	0.000132	0.000325	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CYP2E1—obesity	0.000127	0.000313	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—NQO1—obesity	0.000126	0.00031	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—GCG—obesity	0.000121	0.000297	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—SLC2A4—obesity	0.000121	0.000297	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CYCS—obesity	0.000119	0.000293	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—GOT1—obesity	0.000117	0.000287	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—GGT1—obesity	0.000117	0.000287	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—NCOA1—obesity	0.000115	0.000283	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—STK11—obesity	0.000114	0.000279	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CYP19A1—obesity	0.000114	0.000279	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—COMT—obesity	0.000106	0.000259	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PPARGC1A—obesity	0.000104	0.000256	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—GNB3—obesity	0.000104	0.000256	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—HMOX1—obesity	0.000104	0.000255	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—GNAS—obesity	0.000101	0.000249	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—APOB—obesity	9.93e-05	0.000244	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—LPL—obesity	9.48e-05	0.000233	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—GPX1—obesity	9.25e-05	0.000227	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CD36—obesity	9.01e-05	0.000221	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—MTHFR—obesity	8.53e-05	0.00021	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PPARA—obesity	8.37e-05	0.000206	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—AGT—obesity	8.11e-05	0.000199	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—APOE—obesity	7.94e-05	0.000195	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CAV1—obesity	7.87e-05	0.000193	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—APOA1—obesity	7.85e-05	0.000193	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PIK3CG—obesity	7.17e-05	0.000176	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PPARG—obesity	6.92e-05	0.00017	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—POMC—obesity	6.82e-05	0.000168	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—INS—obesity	6.79e-05	0.000167	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PIK3CD—obesity	6.3e-05	0.000155	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ALB—obesity	6.22e-05	0.000153	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PIK3R1—obesity	5.95e-05	0.000146	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—NOS3—obesity	5.95e-05	0.000146	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PIK3CB—obesity	5.49e-05	0.000135	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PTGS2—obesity	5.44e-05	0.000134	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PIK3CA—obesity	3.35e-05	8.23e-05	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—AKT1—obesity	2.74e-05	6.72e-05	CbGpPWpGaD
